Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interactive neural-network-assisted screening. A clinical assessment

L J Mango1, P W Radensky

  • 1Neuromedical Systems, Inc., Suffern, New York 10901-4114, USA.

Acta Cytologica
|February 28, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inpatient costs of major cardiovascular events.

American journal of cardiovascular drugs : drugs, devices, and other interventions·2004
Same author

Reimbursement for anticoagulation services.

Journal of thrombosis and thrombolysis·2001
Same author

The estimated cost of managing focal spasticity: a physician practice patterns survey.

Neurorehabilitation and neural repair·2001
Same author

Application of legal and regulatory rules and policies to benchmarking systems.

The Journal of ambulatory care management·2001
Same author

Hospital use and costs among patients with nonischemic cardiomyopathy in the first prospective randomized amlodipine survival evaluation study.

Clinical therapeutics·1999
Same author

Performance of a semiautomated Papanicolaou smear screening system: results of a population-based study conducted in Guanacaste, Costa Rica.

Cancer·1998

Interactive, neural network-assisted (INNA) screening enhances cervical cancer detection sensitivity. This AI tool improves upon unassisted screening, offering higher accuracy in identifying abnormalities.

Area of Science:

  • Medical technology
  • Artificial intelligence in healthcare
  • Gynecologic oncology

Background:

  • Cervical cancer screening relies on accurate detection of epithelial abnormalities.
  • Current screening methods have limitations in sensitivity.
  • Interactive, neural network-assisted (INNA) systems offer potential improvements.

Purpose of the Study:

  • To evaluate the clinical utility and effectiveness of INNA systems in cervical screening.
  • To compile and analyze data from existing clinical studies on INNA screening.
  • To provide quantitative metrics for INNA system performance.

Main Methods:

  • Systematic review and meta-analysis of published and unpublished clinical studies.
  • Development of a taxonomy to classify study results.

Related Experiment Videos

  • Data pooling based on study design and effectiveness metrics.

    • Main Results:

    • INNA sensitivity estimates range from 89% to 100%.
    • Relative yield metrics indicate 8% to 49% improvement over unassisted screening.
    • INNA screening showed 18-40% increase in abnormality yield in primary screening modes.

    Conclusions:

    • A substantial evidence base supports the use of INNA screening.
    • INNA screening demonstrates superior sensitivity for cervical epithelial abnormalities compared to unassisted methods.
    • INNA systems can be effectively used in both substitutive and augmentative roles.